Objective: Chronic ischemia of the upper extremity requiring surgical revascularization is an uncommon condition. We analyzed modes of presentation, methods of operative repair, and follow-up in all consecutive patients with chronic ischemia of the upper extremity requiring arterial bypass. Methods: Data prospectively entered into a vascular registry was retrospectively analyzed for all patients undergoing upper extremity arterial bypass from January 1, 1990, to June 30, 2003. Simple thromboembolectomy procedures and bypasses to an outflow target more proximal than the brachial artery were excluded. Results: We identified 20 patients. Their mean age was 57 years, and 11 (55%) were women. Eight (40%) had diabetes, and five (25%) had renal insufficiency. Indications included exercise intolerance in 11 patients (55%), tissue loss in six (30%), and rest pain in three (15%). The etiology of ischemia was atherosclerosis in seven patients (35%) and complications of iatrogenic or civilian trauma in 13 (65%). The brachial artery was used as the inflow in 13 patients (65%), the axillary in six (30%), and the ulnar in one (5%). Conduits used included the great saphenous vein in 11 patients (55%), arm vein in 7 (35%), and prosthetic in 2 (10%). Outflow targets included the brachial artery in 12 patients (55%), the radial in five (25%), and the ulnar in three (15%). There were no perioperative deaths. One graft (5%) occluded <30 days of surgery. Mean follow-up was 12 months. Mean survival after bypass was 62 months. Patency at 1 and 3 years was 85%. Two patients had associated minor amputations (a finger and a partial hand). Limb salvage rate was 100%. Conclusion: Although upper extremity ischemia is rare, results for upper extremity bypass are excellent and superior to those reported for lower extremity ischemia. These results may reflect the indications, which differ considerably from those for lower extremity bypass, with the most being performed for complications of trauma. ( J Vasc Surg 2007;46: 303-7.)
Arterial reconstruction for the treatment of chronic upper extremity ischemia is infrequently performed in a vascular surgical practice. Furthermore, many of the relatively few reports documenting the results of such operations have included bypass for both acute and chronic ischemia as well as bypass to the subclavian and axillary arteries. [1] [2] [3] [4] This study was undertaken to report our experience with arterial reconstruction of the upper extremity for the treatment of chronic ischemia, focusing exclusively on bypass to the brachial and infrabrachial arteries.
METHODS
The vascular registry of a single university hospital was searched to identify those patients who had a brachial or infrabrachial artery as an outflow target in all consecutive upper extremity arterial reconstructions performed between January 1990 and June 2003. Thromboembolectomy procedures (with or without patch angioplasty) and bypasses with an outflow target more proximal than the brachial artery were excluded. Also excluded were patients undergoing bypass for ischemia related to acute trauma and those who had undergone a previous ipsilateral angioaccess procedure.
Patients presenting with exercise intolerance, rest pain, or tissue loss underwent an initial clinical assessment, followed by preoperative arterial imaging. Preoperative duplex ultrasound vein mapping was used liberally to locate a suitable venous conduit. Any necessary débridement of gangrenous tissue was done preoperatively (for wet gangrene) or at the time of operation. No perioperative amputations were done in this group.
Postoperatively, patients were followed up at regular intervals of about every 3 months during the first year, every 6 months during the second year, and annually thereafter. Graft patency was determined by the presence of a palpable pulse in the graft by the attending surgeon. In the latter years of the study, duplex graft surveillance was often used, although this was not done universally. Death during follow-up was determined from the Social Security Death Index. In a limited fashion, patient demographics and indications for bypass in this group were then compared with a cohort of lower extremity bypass patients at our institution 5 (bypasses performed from July 1990 to July 1993).
All data were prospectively entered at the time of treatment into a vascular registry and the registry updated periodically with patient follow-up information. Data included demographics, indications for surgery, comorbid conditions, specific operative details, complications, and outcomes. A retrospective query of the database and chart reviews were done for this study. All data are presented in accordance with the revised reporting standards of the Joint Council of The Society for Vascular Surgery and The American Association of Vascular Surgery. 6 Graft patency, limb salvage, and patient survival were calculated using the Kaplan-Meier life-table method. Comparisons were made using the nonparametric Mantel-Cox log-rank test. Categoric variables and continuous variables were compared with the 2 and Student t test, respectively. A value of P Ͻ .05 was considered statistically significant.
RESULTS
From January 1990 to June 2003, 20 bypasses were performed to the brachial or infrabrachial artery in 20 patients. Mean age was 57 years (range, 34 to 80 years), and 11 patients (55%) were women. Nine patients (45%) had hypertension, 8 (40%) had diabetes mellitus, 10 (50%) had coronary artery disease, and 5 (25%) had dialysis-dependent renal failure (4 on hemodialysis and 1 on peritoneal dialysis). Indications for bypass included exercise intolerance in 11 patients (55%), rest pain in three (15%), and tissue loss in six (30%). The etiology of ischemia was atherosclerosis in seven patients (35%) and previously untreated iatrogenic or civilian trauma in 13 (65%). The brachial artery was used as the inflow source in 13 patients (65%), the axillary in six (30%) and the ulnar artery in one (5%). Conduits used consisted of the great saphenous vein in 11 patients (55%), an arm vein in seven (35%), and polytetrafluoroethylene (PTFE) in two (10%). Outflow targets were the brachial artery in 12 patients (60%), the radial artery in five (25%) and the ulnar artery in three (15% ; Table I ).
When patients who had undergone bypass for previously untreated trauma were compared with those undergoing bypass for atherosclerosis (Table II) , some interesting observations were noted, although the very small numbers would not allow for meaningful statistical comparison. The six patients undergoing bypass for tissue loss had atherosclerosis as their etiology, whereas none of the patients with previously untreated trauma had tissue loss. Conversely, all of the patients undergoing bypass for exertional symptoms were patients with previously untreated trauma. Also, four of the five patients with dialysis-dependent renal failure were patients undergoing bypass for atheroscle-rosis. Another worthwhile observation was that five (71%) of seven patients with atherosclerosis had undergone a previous lower extremity bypass compared with three (23%) of 13 patients who had previously untreated trauma. Patients undergoing bypass for atherosclerosis also tended to have more distal outflow targets, with five (71%) of seven having an infrabrachial outflow artery compared with three (23%) of 13 for the previously untreated trauma subgroup of patients.
There were no perioperative deaths, no perioperative cardiac complications, and no incidence of postoperative pulmonary or renal failure in this series of upper extremity bypass patients. Average length of stay was 3 days (range, 1 to 7 days). One bypass graft (5%) occluded on postoperative day 12 without attempted revision. Revision was not attempted because an intraoperative decision had been made that in consideration of the borderline nature of the distal target, reoperation would not be undertaken if the graft failed. This was in a 40-year-old woman (Table III , patient 1), with diabetes mellitus, hypertension, coronary artery disease, and chronic renal failure on hemodialysis who underwent a brachial-to-radial artery bypass using cephalic vein for gangrenous fingers caused by atherosclerotic occlusive disease. She subsequently underwent a partial hand amputation of the fourth and fifth digits, including their metacarpal bones, on postoperative day 20. This patient died 9 months postoperatively for complications related to ischemic bowel.
Two additional patients sustained graft occlusion during the follow-up period, which averaged 12 months (range, 1 to 50 months). One patient, a 53-year-old man who was an active smoker with a history of diabetes, hypertension, and congestive heart failure, had undergone an axillobrachial bypass with reversed great saphenous vein for atherosclerotic occlusive disease causing rest pain (Table III, patient 7) . This patient was noted to have graft occlusion on a follow-up visit 4 months postoperatively. Revision was not attempted, and he continued to have only mild ischemic symptoms at follow-up 41 months postoperatively.
The third patient with graft occlusion was a 49-year-old woman who had undergone a brachial-to-ulnar artery bypass with reversed great saphenous vein for exercise intolerance resulting from brachial artery occlusion related to neglected trauma (Table III, patient 10) . Her graft occluded on postoperative day 31. No revision was attempted, and she was noted to have developed a palpable radial pulse 4 months postoperatively. At follow-up 50 months after her bypass, she was asymptomatic.
In addition to the patient with partial hand amputation (Table III , patient 1), a second patient underwent a third finger amputation. This 38-year-old man had a history of diabetes mellitus, hypertension, coronary artery disease, and chronic renal failure on peritoneal dialysis. He underwent a brachial-to-radial artery bypass with reversed great saphenous vein for atherosclerotic occlusive disease causing finger gangrene (Table III, Primary patency, secondary patency, and limb salvage were 85%, 85%, and 100%, respectively, at 1 and 3 years. Patient survival was 77% at 1 year and 56% at 3 years. Of note, 3-year patient survival after bypass was 0% for the renal failure population versus 100% for those without renal failure (Fig 1) .
DISCUSSION
Upper extremity arterial reconstruction is an infrequently performed operation, accounting for approxi-mately 4% of all vascular surgical procedures. 7, 8 First reported by Garrett et al 9 in 1965, relatively few reports on the subject have been published. Publications focusing on brachial artery reconstruction are particularly rare in the literature. This is one of the few studies available on bypasses to the brachial and infrabrachial arteries for the treatment of chronic ischemia.
As noted by Roddy et al, 10 unique demographic differences exist between upper and lower extremity bypass populations. Patients with upper extremity reconstruction typically presented at a relatively early age (average age, 57 in our study and 58 in Roddy et al) with a female preponderance (55% women in our study and 55% women in Roddy et al). In contrast, a contemporary cohort of lower extremity bypasses performed at our institution had a mean age of 67 with a primarily male preponderance (62%). 5 Similar to Roddy et al, we also noted a statistically significant difference in the incidence of diabetes mellitus of 40% in upper extremity bypass patients compared with 83% in the lower extremity bypass population. Differences in the incidence of hypertension, coronary artery disease, congestive heart failure and tobacco use were not statistically significant (Table IV) . Most striking, however, was the difference in the indication for bypass, with 55% of upper extremity patients having exercise intolerance (claudication equivalent) as their indication compared with only 6% of lower extremity patients (Table V) . This may not be entirely surprising, because the inability to use an arm would be expected to be more likely to interfere with one's activities of daily living. The benign postoperative course seen in this series, with absence of mortality or any major postoperative complication may, perhaps, justify the high percentage of patients whose surgical indication was exercise intolerance.
It must be emphasized that comparison with a lower extremity bypass population could only be made in the most general of terms because these two groups of patients differ largely in terms of their etiology of occlusive disease. Although the small patient sample size does not allow us to authoritatively conclude, the trends may allow one to speculate that as would most likely be expected, the atherosclerotic subpopulation of upper extremity bypass patients is most likely to behave like the typical peripheral arterial disease patient seen in a vascular surgical practice (Table II) .
Our patency and limb salvage rates of 85% and 100% respectively at 1 year are similar to what has been previously reported in the literature. Roddy et al 10 reported a 1-year patency of 90% and limb salvage rate of 100%, and Brunkwall et al 11 reported a 1-year patency rate of 96%. It has been previously noted that more proximal reconstructions to the brachial artery tend to fare better than bypasses to the infrabrachial arteries, analogous to what is commonly known in lower extremity arterial reconstruction. 1 Unfortunately, our small sample size did not allow us to make meaningful comparisons between these two groups. Perhaps, not unexpectedly, the two patients in the series who required an amputation (finger amputation and partial hand amputation) were both patients with dialysisdependent renal failure. This is not surprising, because the propensity for finger gangrene to develop in chronic renal failure patients has been previously noted. 12 Even though the subpopulation of renal failure patients in this study had a benign postoperative course, it is important to note that the tendency of this patient population toward a poor postoperative course after both upper and lower extremity arterial reconstruction has been well documented by us and others. 13, 14 The difference in 3-year patient survival of 0% for the renal failure population versus 100% for those without renal failure achieved statistical significance (Fig) , suggesting that the need for an upper extremity bypass in a renal failure patient may well be a clinical marker for pending mortality. 12 One important limitation of this study is that functional outcome data were not recorded. This shortcoming prevents us from the ability to assess if revascularization led to an improvement in the work status of these patients.
CONCLUSION
Upper extremity arterial reconstruction for the treatment of chronic ischemia may be safely undertaken with excellent results. That the etiology of ischemia for most of the patients undergoing bypass was for previously untreated trauma rather than atherosclerosis may account for the superior patency observed compared with those reported for lower extremity bypass. It is our belief that bypass to the brachial and infrabrachial arteries may be offered to appropriately selected patients with upper extremity ischemia. 
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